FI832989A - Foerfarande foer framstaellning av benzamidderivat - Google Patents

Foerfarande foer framstaellning av benzamidderivat Download PDF

Info

Publication number
FI832989A
FI832989A FI832989A FI832989A FI832989A FI 832989 A FI832989 A FI 832989A FI 832989 A FI832989 A FI 832989A FI 832989 A FI832989 A FI 832989A FI 832989 A FI832989 A FI 832989A
Authority
FI
Finland
Prior art keywords
benzamidderivat
foerfarande foer
foer framstaellning
framstaellning
foerfarande
Prior art date
Application number
FI832989A
Other languages
English (en)
Finnish (fi)
Other versions
FI832989A0 (fi
Inventor
Michael John Ashton
David Charles Cook
Colin James Daniels
Anthony Howard Loveless
Jeremy David Pratt
Bernard Thomas Bull
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI832989A0 publication Critical patent/FI832989A0/fi
Publication of FI832989A publication Critical patent/FI832989A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI832989A 1982-08-24 1983-08-22 Foerfarande foer framstaellning av benzamidderivat FI832989A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (2)

Publication Number Publication Date
FI832989A0 FI832989A0 (fi) 1983-08-22
FI832989A true FI832989A (fi) 1984-02-25

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832989A FI832989A (fi) 1982-08-24 1983-08-22 Foerfarande foer framstaellning av benzamidderivat

Country Status (23)

Country Link
US (1) US4507315A (no)
JP (1) JPS5955873A (no)
KR (1) KR840005717A (no)
AT (1) ATA301083A (no)
AU (1) AU1818083A (no)
BE (1) BE897580A (no)
CA (1) CA1195993A (no)
CS (1) CS240973B2 (no)
DE (1) DE3330403A1 (no)
DK (1) DK386783A (no)
ES (2) ES525099A0 (no)
FI (1) FI832989A (no)
FR (1) FR2532310B1 (no)
GB (1) GB2126225B (no)
GR (1) GR78673B (no)
IL (1) IL69544A0 (no)
IT (1) IT1169775B (no)
LU (1) LU84974A1 (no)
NL (1) NL8302947A (no)
NO (1) NO833024L (no)
PT (1) PT77219B (no)
SE (1) SE8304545L (no)
ZA (1) ZA836191B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CN101061116A (zh) * 2004-09-24 2007-10-24 詹森药业有限公司 磺酰胺化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
FI832989A0 (fi) 1983-08-22
IL69544A0 (en) 1983-11-30
GB2126225B (en) 1985-10-09
FR2532310A1 (fr) 1984-03-02
ATA301083A (de) 1985-11-15
ES8502691A1 (es) 1985-01-16
ES528012A0 (es) 1985-06-16
BE897580A (fr) 1984-02-23
ES525099A0 (es) 1985-01-16
IT1169775B (it) 1987-06-03
GB8322539D0 (en) 1983-09-21
NL8302947A (nl) 1984-03-16
NO833024L (no) 1984-02-24
JPS5955873A (ja) 1984-03-31
US4507315A (en) 1985-03-26
KR840005717A (ko) 1984-11-16
PT77219A (fr) 1983-09-01
CA1195993A (en) 1985-10-29
ES8505935A1 (es) 1985-06-16
IT8322629A0 (it) 1983-08-24
GB2126225A (en) 1984-03-21
DK386783A (da) 1984-02-25
CS612483A2 (en) 1985-06-13
SE8304545D0 (sv) 1983-08-22
LU84974A1 (fr) 1984-03-23
FR2532310B1 (fr) 1986-01-10
DK386783D0 (da) 1983-08-23
GR78673B (no) 1984-09-27
SE8304545L (sv) 1984-02-25
ZA836191B (en) 1984-04-25
AU1818083A (en) 1984-03-01
CS240973B2 (en) 1986-03-13
DE3330403A1 (de) 1984-03-01
PT77219B (fr) 1986-02-04

Similar Documents

Publication Publication Date Title
FI830173L (fi) Fyllblandning av polyesterfibrer
FI831325A0 (fi) Framstaellning av aromater
FI831520L (fi) Foerfarande foer framstaellning av hydroxialkylmetylcellulosa
FI832113A0 (fi) Framstaellning av vinylkarboxylsyraderivat
FI64260B (fi) Anordning foer foerdelning av en stroemning
FI832817A0 (fi) Foerfarande foer framstaellning av alfaarylalkanosyror
FI830988L (fi) Foerfarande foer behandling av loesningar foer underlaettande av avlaegsnandet av ferrijaern
FI832036L (fi) Foerfarande foer framstaellning av oxazolaettiksyra
FI821044L (fi) Taetning av ventillock
FI831535A0 (fi) Reaktor foer framstaellning av klordioxid
FI832989A0 (fi) Foerfarande foer framstaellning av benzamidderivat
FI833551A0 (fi) Tillverkning av magnesiumnitratloesningar
FI822473A0 (fi) Foerfarande foer utfoering av mutagenitettest
FI831647L (fi) Foerfarande foer spraytorkning av dipeptidsoetningsmedel
FI821879L (fi) Foerfarande foer framstaellning av trifenylbutenderivat
FI832362A0 (fi) Foerfarande foer framstaellning av fenetylaminer
FI833930A (fi) Framstaellning av aminocyklopentansyror
FI830905A0 (fi) Foerbaettringar av dimensionsstabiliserat papper
FI820403L (fi) Foerfarande foer framstaellning av betongmassa
FI65584B (fi) Anordning foer snabbkoppling av en stockbom
FI824222A0 (fi) Ramkonstruktion foer en tryckslipmaskin av presstyp
FI821329L (fi) Anvaendning av faergaemneslaser
FI820550L (fi) Foerfarande foer styrning av manuell bearbetningsmaskin
FI820789L (fi) Foerfarande foer bildande av en vertikaldraen
FI834218A0 (fi) Behandling av traevaror

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: MAY & BAKER LIMITED